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The obese iob/ob) mouse exhibits an inability to
 
synthesize leptin and thus serves as an excellent model to
 
study the effects of leptin through its reintroduction.
 
Leptin is a hormone produced by adipocytes and has been \
 
shown to upregulate metabolic expenditure and
 
thermogenesis, induce lipolysis, and cause appetite
 
suppression. It has not been established if leptin is able
 
to exert its actions directly or by stimulating the release
 
of thyroid hormone (T3). In this study, twenty C57BL/6J-ob
 
iiormal (+/?) and homozygOuS obese iob/bb) mica bestween the
 
ages of 8-10 weeks were treated for nine days with either
 
saline vehicle, leptin, iopanoic acid, or leptin plus
 
iopanoic acid (n=5/group). Iopanoic acid was used to
 
prevent leptin from inducing the conversion of T4 into T3.
 
Daily measurements of body weight, food consumption, oxygen
 
consumption, carbon dioxide production, and infrared
 
emission were collected in both +/? and ob/ob treatment
 
groups. Iopanoic acid was ineffective at reducing serum T3
 
in +/? mice, however it successfully reduced T3 synthesis in
 
ob/ob mice relative to vehicle treated ob/ob mice,
 
Vehicle treated ob/ob mice displayed a greater food
 
consumption than vehicle treated +/? mice, while both
 
leptin and ippanpic acid + leptin treatment effectively
 
reduced appetite in oJb/ojb mice below oJb/ob vehicle
 
treatment groups. With respect to vehicle treated ob/ob
 
mice, a lower day 10 body weight was observed ah both
 
leptin and iOpanoic acid + leptin treated bb/^ob mice, while
 
the mean body weights for iopanoic acid treated ob/ob mice
 
remained unchanged. Iopanoic acid was effective at
 
depressing serum T3 in ob/ob mice which also showed a
 
reduction in body weight similar to that of leptin treated
 
ob/ob mice, thus the effect of leptin on weight reduction
 
cannot be attributed to mediation by T3. .
 
Vehicle treated ob/ob mice displayed a lower day 10
 
radiant body heat with respect to vehicle treated +/? mice
 
(31.5 + 0.3 °C vs. 33.9 + 0.4 °C, respectively). Iopanoic
 
acid treated ob/ob mice displayed radiant body heat
 
emission similar to those of vehicle treated ob/ob mice.
 
However, both leptin and iopanoic acid + leptin treated
 
ob/ob mice showed higher radiant body heat than both
 
vehicle and iopanoic acid ob/ob treatment groups. This
 
suggests that the thermogenic effects of leptin are
 
similar in both leptin and iopanoic acid + leptin ob/ob
 
treatment groups. Iopanoic acid was ineffective at
 
reducing serum T3 in +/? Mice, however it successfully
 
reduced T3 synthesis in oJb/oJb mice relative to vehicle
 
treated ob/ob mice. Thus the reduction of serum T3 ih the
 
iopanoic acid + leptin treatment group shows that this
 
thermogenic influence of leptin occurs without increasing T3
 
concentrations.
 
Vehicle treated ob/ob mice had the highest serum T3
 
concentrations relative to all other treatment groups, and
 
they also displayed total oxygen consumption rates similar
 
to vehicle treated +/? mice (3.8 + 0.8 ml O2' min'^ vs. 3.9
 
+ 0.6 ml O2 * min"^, respectively). The reduction of T3 in
 
iopanoic acid treated ob/ob mice caused a decline in oxygen
 
consumption, relative to vehicle treated ob/ob mice (2.6 +
 
0.8 ml O2' min'^ vs. 3.9 + 0.6 ml O2' min"^, respectively).
 
An elevated metabolic rate in both leptin and iopanoic acid
 
+ leptin ob/ob mice relative to iopanoic acid treated ob/pb
 
mice suggests that leptin is acting through T3 to induce
 
metabolism. Leptin deficient iopanoic acid treated ob/ob
 
mice display low serum T3 relative to vehicle treated ob/ob
 
mice, and consequently have low metabolic rates relative to
 
the same control group. Administration of leptin to
 
iopanoic acid + leptin ob/ob mice resulted in a similarly
 
elevated metabolic rate without an increasing serum T3.
 
This confirms that metabolic expenditure can be induced by
 
leptin and without indirectly increasing serum T3
 
concentrations.
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CHAPTER ONE: INTRODUCTION
 
Thermogenesis from Oxidative Metabolism
 
The development of obesity is a major complication
 
associated with the pathology of Non Insulin Dependent
 
Diabetes Mellitus (NIDDM). Increased body weight is
 
inversely proportional to insulin sensitivity and thus
 
contributes to a decreased ability to transport glucose
 
into the cells resulting in hyperglycemia. Weight loss
 
improves both insulin sensitivity and glycemic control in j
 
obese individuals suffering from NIDDM. Thus researchers
 
are looking at mechanisms of inducing metabolic expenditure
 
in order to mobilize stored fat reserves and to ultimately
 
reduce body weight and lead to an improvement of the
 
diabetic state.
 
The production of heat resulting from overall energy
 
expenditure is categorized by Himms-Hagen (1989) as either
 
obligatoiry or facultative thermogenesis. The amount of
 
heat produced through obligatory thermogenesis is
 
relatively low and results from thermic effects of food
 
ingestion and energy expended during growth, pregnancy, and
 
lactation. Facultative thermogenesis results from
 
metabolic processes which can be rapidly regulated and
 
includes exercise-stimulated thermogenesis, involuntary
 
skeletal muscle shivering, and nonshivering thermogenesis.
 
The overall metabolism of all tissues is responsible for
 
maintaining obligatory thermogenesis while facultative
 
thermogenesis is primarily observed in skeletal muscle and
 
brown adipose tissue. Targeting facultative thermogenic
 
tissue to increase energy expenditure has recently become a
 
candidate for the treatment of obesity.
 
The specific metabolic events contributing to
 
facultative thermogenesis occur as a by-product of
 
oxidative metabolism. A comparison of the change in
 
enthalpy for cellular substrate oxidation to that of ATP
 
hydrolysis shows that the cellular production of heat
 
mainly occurs in the process of ATP production as opposed
 
to ATP usage (Prusiner and Poe, 1968). The donation of
 
electrons to the mitOGhondrial electron transport system
 
through the oxidation of reduced nucleotides produces a
 
electrochemical gradient which is then dissipated through
 
the inner membrane bound Fi/Fo/ATP syhthase and results in
 
the phosphorylation of ADP. Much research has focused
 
attention on the mechahism and regulation of uncoupling
 
metabolic oxidation from the phosphdrylation of ADP.
 
In order to uncouple oxidative phosphorylation the
 
mitochondrial electrocheinical gradient is dissipated
 
through an inner membrane protein called uncoupling protein
 
(UCP) (Klingenberg et. Al., 1985). As a result of
 
mitochondrial uncoupling, substrate utilization and oxygen
 
consumption are maintained or can be potentially
 
upregulated while ATP synthesis is no longer tightly
 
coupled to the oxidation of substrates. Scientists have
 
directed their attention towards this inner mitochondrial
 
membrane bound uncoupling protein as a candidate for
 
inducing metabolic expenditure and thus ultimately reducing
 
body weight. The normal role of this protein is to
 
dissipate the hydrogen ion electrochemical gradient
 
established through oxidative metabolism and ultimately
 
result in heat production for the maintenance of body
 
temperature in hoiheothermic animals (the detailed mechanism
 
will be discussed in the next section). Clinical induction
 
of uncoupling protein (UCP) will permit increased metabolic
 
expenditure while not increasing ATP synthesis, and heat
 
will be produced as a metabolic by-product thus allowing
 
adipose reserves to be increasingly mobilized thus serving
 
as a substrate for this thermogenic process.
 
Thermogenic Tissues
 
Facultative thermogenesis is divided into heat
 
produced through muscular activity and excercise.
 
shivering, and non-shivering thermogenesis (Schmidt-Nelson,
 
1990). Shivering thermogenesis results from acute
 
involuntary skeletal muscle contraction and aids in
 
maintaining body temperature during drastic environmental
 
temperature changes. Non-shivering thermogenesis was
 
initially described to function in the thermal balance of
 
mammals undergoing cold acclimation, in small mammals
 
arising from hibernation, and in newly born mammals. Brown
 
adipose tissue was initially established as the organ
 
responsible for the mechanism underlying this thermal
 
balance (Himms-Hagen, 1990).
 
The role of brown adipose tissue as a contributor.to
 
whole body thermogenesis is related to its structural
 
composition. Brown adipose tissue consists of
 
approximately 40% brown adipocytes with the remaining mast
 
cells, interstitial cells and preadipocytes that
 
differentiate into brown adipocytes. The characteristic
 
brown color of BAT is the result of high densities of
 
mitochondria with iron containing cytochromes. The rich
 
vasculature of BAT permits the flow of blood from this
 
tissue to be rapidly dispersed to tissues and organs of the
 
body (Himms-Hagen, 1990).
 
The contribution of BAT to nonshivering thermogenesis
 
in newborn mammals was partly established through studies
 
performed by Heim and Hull (1968) which demonstrated that
 
BAT in newborn rabbits accounts for at least 70% of the
 
increased oxygen consumption following norepinephrine
 
infusion. Himms-Hagen (1?89) found a tight correlation
 
between the species-specific thermal requirement and brown
 
fat development. For example, mamma.ls born well developed
 
and able to live independently very early in life, such as
 
the dog and guinea pig, have BAT which is fully developed
 
at birth and atrophies shortly therea-fter. However mammals
 
such as the Syrian hamster, which is born poikilothermic,
 
initiates BAT development at approximately 2 weeks of age,
 
when it is able to maintain a constant body temperature.
 
After it was established that BAT is a major contributor to
 
thermoregulation, researchers began proposing it as a
 
potential target to induce metabolic expenditure (Himms-

HageUj 1989). Unfortunatelyj adult human's lack sufficient
 
quantities of BAT to influence total body temperature and
 
thus specific inductive targeting of BAT could hot
 
sufficiently mobilize stored fat reserves and cause a
 
decrease in body weight. Brown adipose tissue is not the
 
only tissue responsible for maintaining heat balance
 
through non-shivering thermogenesis, Recent research has
 
demonstrated that the uncoupling mechanism responsible for
 
heat production in brown adipose tissue is also found
 
within other thermogenic tissues of the body, namely
 
skeletal muscle (Ross et al., 1997).
 
When the mechanism of thermogenic uncoupling was
 
discovered to be homologous in skeletal muscle to that of
 
brown adipose tissue researchers began looking at muscle as
 
a target for metabblic induction in humans suffering from
 
obesity. Skeletal muscle constitutes 42% of body mass in
 
both humans and rats and, due to its high mass, greatly
 
contributes towards whole body oxygen consumption relative
 
to other tissue types. Therefore many investigators
 
support it as a primary tissue for clinically targeting the
 
induction of metabolic uncoupling and the treatment of
 
obesity.
 
History of Uncoupling Protein
 
During the early to mid 1970's research focussed on
 
the influence of fatty acids on the induction of oxidative
 
uncoupling and nucleotides inducing recoupling in BAT
 
mitochondria (Cannon et al., 1973; Rafael et al., 1969;
 
Hittelman et al., 1969). Heaton et al. (1978) identified a
 
32,000-Mr protein responsible for proton conductcuice.
 
However it remained uns«^ttled as to this newly
 
discovered protein was resppnsible for the lionshivering
 
thermdgenesis attributed to torOwri fat1 Support fob this
 
came from an pbserved correlation betWeen the thermogenic
 
output and the newly discovered 32,00G-Mr protein in animals
 
which vary in thermogenic capacity {Nicholls and Locke,
 
1984). For instance, the decline in npnshivering
 
thermogehesis during guihea^^^^^^ correlates with
 
the decline in both the amount of the 32,000-Mr protein, and
 
the proton conductance of the inner mitochondrial membrane
 
(Nicholls and Locke, 1984). This particular uncoupling
 
protein was isolated by Lin and Klingenberg (1982) and
 
found to be solely expressed in brown adipose tissue (BAT).
 
Several observations led to the hypothesis that
 
mitochondrial uncoupling of oxidative phosphorylation
 
exists in tissues other than BAT. It was observed that the
 
inner mitochondrial membranes of isolated intact liver
 
cells were permeable to protons and that cellular oxygen
 
consumption, for the purpose of maintaining the
 
electrochemical gradient against the proton leak, accounted
 
for approximately 26% of the total resting respiration rate
 
in isolated liver cells and approximately 52% of resting
 
rat skeletal muscle (Brand et al., 1994; Rolfe and Brand,
 
1996), These studies confirmed that the proton leak in rat
 
liver, skeletal muscle and heart contribute to an average
 
20% of the standard metabolic rate in the adult rat (Nobes
 
et al., 1990; Brown et al., 1990; Brand et al., 1994; Rolfe
 
& Brand, 1996) The proton leak in these tissues, as well
 
as in brain and kidney, suggested the presence of a
 
mechanism of uncoupling in tissues other than that
 
previously described in BAT (Rolfe et al., 1994). Further
 
evidence supporting the need for a mechanism to regulate
 
energy expenditure in tissues other than BAT was that adult
 
humans have very little BAT (Cunningham et al., 1985;
 
Garruti et al., 1993; Lean et al., 1986). Furthermore,
 
although obese mice demonstrate atrophied BAT and low
 
thermogenic output, mice where UCP is not expressed in BAT
 
are not always obese. This compounding evidence led to
 
studies in which several other UCP's, with high homology to
 
the UCP expressed in BAT (now defined as UCPl), were
 
identified and characterized (tablel): UCP2 (Fleury et
 
al., 1997; Gimeno et al., 1997; Boss et al., 1997), UCP3
 
(Boss et al., 1997; Solanes et al., 1997), and UCP4 (Mao et
 
al., 1999).
 
Table 1. Uncoupling proteins and the tissue types
 
where they have been isolated. BAT=brown adipose
 
tissue, WAT=white adipose tissue, SM=skeletal
 
muscle
 
Uncoupling Protein Type	 Tissue
 
UCP2	 BAT, WAT, SM, Heart
 
Kidney, Lung, Placenta
 
Lymphocytes
 
UCP3	 BAT, SM
 
UCP4	 Brain
 
Characteristics of Uncoupling Protein
 
All UCP's belong to the gene family of mitochondrial
 
anion carrier proteins which include the ATP/ADP
 
translocator, the phosphate carrier, the
 
2-oxygluturate /malate carrier, and the citrate carrier
 
(Palmier, 1994). All members of this family have three
 
highly conserved repeated domains. Two transmembrane
 
domains exist within each repeating unit and a highly
 
conserved basic motif, containing the amino acid residues
 
allbnb (a=acidic, l=lipophilic, b=basic, n=neutral), occurs
 
 after the first transmembrane domain of each repeat
 
(Klingennberg, 1993). Human UCPl and UCP2 are 59%
 
identical at the amino acid level, and UGP3 is 57% and 71%
 
identical to UCPl and UCP2, respectively (Vidal-Puig et
 
al., 1997). UCP3 exists in a both short and a long forms
 
(Boss et al., 1997; Solanes et al., 1997); the short form
 
of UCP3 is missing 37 amino acids at the C-terminus that
 
are present in the long form and which are also found in
 
UCPl and UCP2. There is no change in the ratio of long to
 
short form of the transcript in obese and lean subjects
 
before and after caloric restriction (hypocaloric diet of
 
1045kJ/day for 5 days) suggesting the absence of alteration
 
of gene regulation and alternative splicing in the skeletal
 
muscle of obese subjects (Millet et al., 1998). Separate
 
studies by Boss et al. (1997) and Solanes et al. (1997)
 
suggest the C-terminus present in the long form, but not in
 
the short form, contains a transmembrane domain that may
 
function to correctly insert UCP into the membrane.
 
The mechanism by which uncoupling protein facilitates
 
the dissipation of the H"^ gradient across the inner
 
mitochondria! membrane has been described to be driven via
 
fatty acid cycling (Garlid et al., 1996; Jezek et al.,
 
1998). The proposed mechanism of fatty acid cycling works
 
^ ■ 10 
 through a membrane bound domain of the UCP that contains ah
 
anion conductance pathway. The transportating of begins
 
with protination of a membrane bound fatty acid which then
 
flips to the iriatrix and delivers a H"^ down its gradient via
 
nonionic diffusion. The bilayer energy barrier is too high
 
to allow the flux of tha Fatty acid (FA) anion back across
 
the membrane. The energy barrier is reduced by the anion
 
conductance pathway of the UCP. The FA anion flip-flops to
 
the other side of the membrane, along the provided
 
conductance pathway, and becomes protinated for a nonionic
 
diffusion to complete the cycle. UCP2 and UCP3 are
 
suggested tp both facilitate the transport of through the
 
same mechanism of fatty acid Cycling (Jezek et al., 1998).
 
Leptin as a Satiety Factor and Regulatbr of Metabolic
 
Expenditure
 
The ob gene encodes a 167 amino acid peptide called
 
leptin which is expressed in brown a.nd white adipose
 
tissue, placental tissue, and regions along the
 
gastJ^ointestinal tract (Prolo et al., 1998; Auwefx and
 
StaelS/ 1998). Leptin reduces appetite and induces
 
metabolic expenditure by regulating the level of central
 
nervous system activity, specifically the expression of
 
hypothalamic neuropeptide y (NPY). The NPY is a stimulator
 
■ 11' ■ 
of feeding and inhibitor of brown fat uncoupling^^^^^p^^
 
thermogehesis activity (kotz et al. ,■ i598)v. Leptih has 
been shown to inhibit NPY release frort the h^othalam 
arcuate nucleus and subsequently results in decreased 
feeding and an increased BAT UCPl expressioh (Kotz et a.1., 
::T998i V .'C. • 
Leptin's action on peripheral cell activity is the 
result of both direct leptin receptor binding and 
activation of the sympathetic nervous system. 
Catecholamine levels have been shown to rise in a dose 
dependent manner with leptin administration. Adipocyte 
beta-adrenergic receptor binding of catecholamines ­
activates intracellular adenylate cyclase and, through a 
signal transduction cascade, activates triglyceride lipase 
catalyzing the breakdown of triacylglycerol. While 
sympathetic nerve activity increases adipocyte lipolytic 
activity, simultaneous adiopocyte leptin gene expression is 
inhibited. (Hua et al., 1997) . Leptin acts similarly in 
other peripheral tissues to cause the depletion of cellular 
triglycerides. Shimabukuro et al. (1997) demonstrated that 
leptin administration causes skeletal muscle, liver, and 
pancreas cells to break down intracellular triglycerides. 
Furthermore, simultaneous upregulation of free fatty acid 
(FFA) oxidation with leptin infusion was suggested by the
 
absence of an increase in serum FFA content, that should
 
have resulted from the increased cellular lipolysis.
 
Leptin induced depletion of FFA content is supported
 
through a simultaneous upregulation of S-oxidation
 
(Shimabukure et al., 1997). An interesting study performed
 
by Wang et al. (1999) demonstrates through adipocyte cell
 
culture that leptin and norepinephrine independently induce
 
lipolytic activity. Interestingly, norepinephrine
 
induction of lipolysis results in free fatty acid and
 
glycerol release, while leptin lipolytic induction was
 
followed by only glycerol release thus supporting a leptin
 
induced S-oxidation. While leptin is inducing fat
 
oxidation, a simultaneous inhibition of acetyl-CoA
 
carboxylase activity, the rate-limiting enzyme of fatty
 
acid synthesis, by leptin subsequently leads to a reduction
 
of malonyl-CoA (Bai et al., 1996). Since malonyl-CoA
 
directly inhibits carnitylacyltransfeirase I, an enzyme
 
catalyzing the translocation of fatty acid into the
 
mitochondrial matrix, oxidation will ultimately increase.
 
Leptin has also been demonstrated to alter peripheral
 
tissue metabolic expenditure through changes in the
 
magnitude of oxidative uncoupling. Leptin's action as a
 
^3 :
 
regulator of metabolic expenditure on peripheral tissue
 
seems to be partly mediated through sympathetic nervous
 
activity. Haynes et al. (1997) showed that leptin
 
increased sympathetic nerve activity to brown adipose
 
tissue, renal tissue, and the hindlimb. This upregulation
 
of catecholamine production induces lipolytic activity thus
 
resulting in increased serum fatty acid levels (Wang et
 
al., 1999). Hwang and Lane (1999) showed that
 
administration of fatty acids to skeletal muscle cells in
 
vitro results in a time and concentration dependent
 
increased UCP3 mRNA expression. Intralipid infusion mimics
 
the rise in plasma free fatty acid levels that occurs as a
 
result of adipocyte fatty acid mobilization during a fasted
 
state. Weigle et al. (1998) elevated serum free fatty acid
 
levels in fed animals through intralipid infusion (20%
 
Intralipid) and observed an increased skeletal muscle UCP3
 
mRNA. In the same study, fasting rats were observed to
 
increase serum FFA levels 3-fold, accompanied by increased
 
skeletal muscle expression of UCP3 and UCP2 mRNA.
 
The synthesis of catecholamines occur in the CNS,
 
sympathetic postganglionic neurons, and adrenal chromaffin
 
tissue. While both intravenous and intracerebroventricular
 
injection (ICV) of leptin results in increased plasma
 
14
 
catecholamiiie (norepinephrine and epinephrine), ICV
 
injection requires approximately 100 fold less leptin to
 
increase catecholamine secretion (Satoli et al,, 1999).
 
Other ICV leptin injection studies support the idea that
 
fats were mobilized to fuel an increased uncoupling through
 
an observed reduction in the respiratory quotient, shifting
 
from carbohydrate to fat metabolism (Ghibaudi et al.,
 
1996). During the ICV leptin injection study performed by
 
Satoh et al. (1999), both norepinephrine and epinephrine
 
plasma levels remained elevated and without change for 3
 
hours post injection. It is also shown that a continuous
 
leptin ICV infusion of 4 days (12 /xl/day) is able to
 
maintain high levels of UCPl, UCP2, and UCP3 mRNA.
 
Leptin's Action Through Thyroid Hormone
 
Thyroid hormone is synthesized in the thyroid gland
 
through the coupling of iodinated tyrosines to yield both
 
thyroxine (3,4,3S5'-Tetraiodothyronine, T4) and, to a
 
lesser amount, triiodpthyronine (3,5,3'-Triiodothyronine,
 
Ts)! Both T4 and T3 are secreted into the circulation and
 
while T3 is the physiologically active form, T4 must be
 
converted to T3 in order to elict most responses. The
 
conversion of T4 to T3 is catalyzed in the peripheral
 
tissues by either type I or type II T4 5'-monodeiodinase
 
■ ' ■ 15 
(5'-D). Type I 5'-D is responsible for most of the
 
conversion of T4 and is found in the kidneys and liver,
 
whereas type II is found in BAT, brain, and pituitary
 
gland.,;
 
T3 stimulates mitochondrial metabolism and oxygen
 
consumption and thus increases the level of cellular ATP.
 
T3 also increases the expression of plasma membrane bound
 
Na'^/K'^-ATPase expression. Thus both increased levels of ATP
 
along with T3 stimulated Na^/K^-ATPase expression provides
 
the basis for the sodium pump theory of thermpgenesis,
 
which describes the process of ATP hydrolysis by the Na^
 
pump as an exothermic reaction yielding the production,of
 
heat for the maintenance of body temperature. Thyroid
 
hormone (T3) has also been shown to elicit a thermogenic
 
effect through increased mitochondrial proton leak in
 
isolated liver cells (Rolfe and Brand, 1997). Furthermore
 
T3 induced expression of UCPl, UCP2, and UCP3 mRNA is
 
suggested to contribute to thermogenesis (Boss et al.,
 
1997; Gong et al,, (1997).
 
Fehn et al. (2000) reported a similar degree of
 
metabolic stimulation by both leptin and T3 in the ob/ob
 
mouse. However/ the thermogenic and metabolic actions of
 
leptin through T3 have never been described. Our laboratory
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has demonstrated, through hrstological analysis of thyroid
 
glands in obese (ob/qb) mice, an enhanced follicular cell
 
activity and enlarged Colloids with leptin treatment,
 
suggesting increased thyroid hormone in response to leptin
 
(Fehn et 1999). in addition serum it has demonstrated
 
increased serum leptin levels in response to T3 treatment.
 
Thus since both leptin and T3 independently induce
 
thermpgenic uncoupling and T3 synthesis seems to be
 
dependent upon serum leptin levels, it is possible to
 
predict that the thermogenic effect of leptin is through
 
the induction of T3 synthesis.
 
Skeletal Muscle Metabolic Uncoupling
 
Brown adipose tissue (BAT) is well documented to be a
 
major site of nonshivering thermogenesis in rodents however
 
its control is defective in most animal models of obesity.
 
Himms-Hagen (1990) reports that BAT of obese rodents is
 
thermogenically inactive and exhibits a characteristically
 
depressed ability to synthesize uncoupling protein, thus
 
the requirement to thermoregulate in obese animals implies
 
the existence of uncoupling protein in other tissues.
 
Furthermore, the presence of relatively small amounts of
 
BAT in humans supports the need for a mechanism of
 
nonshivering thermogenesis in tissues other than BAT. The
 
discovery of UCP3, expressed primarily in skeletal muscle,
 
led Inyestigatdrs to target it as^ potential medns of
 
clinically regulating metabolic expenditures to tredt
 
obesity. Interestingly, both leptin and T3 similarly induce
 
the genetic expression of skeletal muscle UCP3 (Liu et al.,
 
1998; Gong et al., 1997).
 
H-uman skeletal muscle lipolysis is induced through S2­
adrenoceptor agonist and not Si- or S3- specific agonists
 
(Hagstrom-Toft et al., 1998). It has not been clearly
 
established if T3 permissively induces the expression or
 
actiyity of skeletal muscle S2-adrenergic receptor in order
 
to permit a catecholamine stimulated skeletal muscle .
 
thermogenic response. Neither has it been established if
 
leptin is able to directly alter skeletal muscle uncoupling
 
in the absence of centrally mediated adrenergic influence.
 
Thus it would be of interest to experimentally prevent the
 
up-regulation of thyroid hormone by leptin and thereby
 
remove the permissive action of T3 on peripheral tissue
 
adrenergic receptors. This would allow investigators to
 
evaluate leptin's action on peripheral tissue activity
 
through adrenergic activity and, in the absence of thyroid
 
hormone's additional influence, would also yield a better
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understanding of the direct action of leptin on peripheral
 
tissue uncoupling.
 
Experimental Design
 
The C57BL/6J obese (ob/ob) mouse exhibits an inability
 
to synthesize functional leptin and is reported to display
 
hypothyroidism (low T3, high T4) from 3 to 6 weeks of age
 
(Oh and Kaplan, 1994). These mice also exibit a reduced
 
oxygen consumption and low body temperature (Kaplan and
 
Leveille, 1974). Daily injection of ob/ob mice with leptin
 
reduces body weight and food intake, while increasing
 
metabolic rate (Pelleymounter et al., 1995). Studies from
 
our laboratory have shown that with leptin administration
 
the ob/ob mouse increases oxygen consximption rates and
 
thermogenesis (Fehn, et al., 1999). The mechanism of
 
leptin stimulation in peripheral tissue metabolic and
 
thermogenic activity in the absence of T3 has not been
 
determined and is the focus of this particular research.
 
As discussed earlier, T3 is synthesized through the
 
deiodination of T4 by T45'-monodeiodinase. In order to
 
evaluate the ability of leptin to stimulate metabolism and
 
thermogenesis we needed to block leptin's ability to
 
stimulate T3 synthesis. lopanoic acid was used to block
 
renal and hepatic T45'-monodeiodinase. Obese ob/ob and
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normal +/? mice were used to measure oxygen consumption,
 
carbon dioxide production, radiant body heat, and food
 
consumption while given either saline vehicle, leptin,
 
iopanoic acid, or leptin in addition to iopanoic acid.
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CHAPTER TWO: MATERIALS AND METHODS
 
Animals
 
Twenty of the C57BL/6J-oJb normal (+/?) and homozygous
 
obese {ob/ob) female mice were ordered from Jackson
 
Laboratories (Bar Harbor, Maine). All mice were ordered to
 
arrive at 8-10 weeks of age r^ initial treatment
 
three days after arrival. Mice were housed at five animals
 
per cage of the same genotype and treatment group and
 
maintained at approximately 23 °C under a 14:10 light:dark
 
cycle. Water and Teklab 4% rodent chow were available ad
 
libitum.
 
Experimental Design
 
Recombinant mouse leptin was purchased from R&D
 
Systems (#498-OB). The leptin formulation was lyophilized
 
from a filtered solution in phosphate buffered saline
 
(PBS). Leptin was reconstituted by adding 15mM sterile HCl
 
(2.5 ml/Smg leptin) to a vial and allowing the protein to
 
dissolve. Once leptin was completely dissolved, 7.5 mM of
 
sterile NaOH (1.5 ml/5mg vial) was added to bring the pH to
 
approximately 5.2. The resulting suspension was aliquoted
 
into microcentrifuge txibes and stored at -20 °C until used,
 
lopanoic acid was purchased from SIGMA Biochemicals
 
(Product Number I 2013) and was prepared immediately before
 
each use by adding 6.25 ml of O.IM NaOH to 125 mg of the
 
drug. Once the drug was dissolved, it was titrated with
 
0.IM HCl to approximately pH 7.8 and then diluted with
 
distilled water to a volume of 12.5 ml and protected from
 
Mice were organized into 4 groups with 5 animals per
 
group. Each group received daily intraperitoneal
 
injections of one of the following; leptin (3 |ig/g body
 
weight; 2.4 /xl/g body weight), iopanoic acid (50.0 /xg/g
 
body weight; 5.0 /il/g body weight), or both leptin and
 
iopanoic acid as a double injection (as described above).
 
Control animals received intraperitoneal injections of _
 
leptin vehicle (PBS pH 5.2; 2.4 jil/g body weight).
 
Injections were administered between the hours of 0800
 
hours and 1200 on nine consecutive days (day 1 through day
 
9) following readings of O2 consumption, CO2 production,
 
radiant body heat, and body weight determinations.
 
Percent change in body weights with respect to day 1
 
were determined for each animal and statistical analysis
 
(ANOVA) was performed on last day percent change. In order
 
to statistically evaluate all values of percent change as
 
positive numbers, a constant of 0.25 was added to the
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percent change of each animal and then arcsin
 
transformation was applied to th^ yalues^^^^ ^
 
Metabolic Rate Determination
 
Oxygen consumption and carbon dioxide production were
 
measured using open flow respirometry with an Ametek S­
3A/II O2 analyzer and an Ametek CD-3A CO2 analyzer,
 
respectively. Room air was utilized as a reference gas and
 
assumed to contain 20.96% O2 and 0.03% CO2. Readings were
 
taken at a constant flow rate of 400 ml per minute. Mice
 
were placed in an open flow container and the fractional
 
gas content was recorded at the end of 2 minutes, a time
 
which was determined to provide stable readings. Animals
 
were weighed after metabolic determination. Results are
 
reported as total oxygen consumption (ml O2 • min'^).
 
Respiratory quotients (RQ, ml COa/ml O2) were determined
 
from oxygen consumption and carbon dioxide production in
 
order to evaluate metabolic substrate usage
 
Food Consumption
 
Daily food consumption was determined for each
 
treatment group by weighing any uneaten food in both the
 
tray and inside mouse cage (moisture accumulation was not
 
detected in uneaten food). Food was weighed under the
 
assuniplrion. that moisture frbm saliva and urnine negligably
 
altered weight. Food consumption measurements were begun
 
the same day of treatments and thus pretreatment data are
 
not available. Mean daily food consumption (grams/day) was
 
measured for each group of five mice on each day of the
 
study. Data was analyzed for the last three days (days 8­
10).
 
Radiant Body heat Determination
 
Radiant body heat was deteimined daily using a
 
thermocouple thermometer (Dual J-T-E-K, model 91100-40)
 
with an infrared probe (Cole Farmer, model 39652-10 K).
 
The probe was positioned approximately 2 cm from the
 
ventral surface of the animal's lower abdomen and held.
 
until a constant value was obtained (approximately 15
 
seconds). Radiant body heat was recorded in °C and used as
 
an indicator of thermogenesis.
 
Blood Collection and Serum Thyroid Hormone Determination
 
Blood was collected via cardiac puncture, and then
 
sacraficed by CO2 euthanasia. Blood samples were transferred
 
to 1.5 ml microcentrifuge tubes and placed on ice until
 
clotted. Serum was separated from the clot by
 
centrifugation (15,000 xg) and stored at -20 °C until
 
assayed. All samples were subjected to radoimmunoassay
 
quantification of T3 and T4 using the T3 Solid Phase
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Component System and the T4 Mab Solid Phase Component
 
System (ICN Pharmaceuticals, T3 06B-254215; T4 O6B-254011).
 
Standards for the T3 kit ranged from 0 ng/dL to 800 ng/dL L-

Triiodothyronine in human serum with sodium azide.
 
Standards for the T4 kit ranged from 0 fig/dL to 20 fig/dli L-

thyroxine in hviman servim with sodium azide.
 
Statistical Analyses
 
All day 10 results were subjected to multifactorial
 
analysis of variance (ANOVA) and Duncan's Multiple Range
 
Test (Mason et al., 1989). Statistical significance is
 
shown in a chart below each figure or table where treatment
 
groups intersect (S = significance; NS = not significant).
 
Missing data points occurred in the following thyroid
 
hormone groups: vehicle treated +/? T3, and iopanoic acid
 
treated ob/ob T3. Subsequently, these same groups had
 
missing data for the T3/T4 determinations. After
 
calculating the ratio (T3/T4) for vehicle treated ob/ob
 
mice, there was an outlier that was also removed as a
 
missing data point. Missing data points were estimated by
 
the method of Zar, (1984).
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A'+S-a.
 
For each group where missing data occurred, ANOVA was
 
calculated as n=4. All other ANOVA calculations were
 
reported using n=5 (mean + SD). P values 0.05 are
 
declared significant.
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RESULTS
 
Serum Thyroid Hormones
 
Serum thyroid hormone (T3) concentrations in vehicle
 
treated 8-10 week old ob/ob mice were greater than in the
 
normal vehicle treated group (table 2). Obese mice treated
 
with leptin, iopanoic acid, and iopanoic acid + leptin
 
displayed a lower serum T3 concentrations relative to
 
vehicle treated ob/ob mice and were not different from
 
nomal treatment groups. Iopanoic acid + leptin treated
 
ob/ob mice displayed a higher ser\im T4 than leptin treated
 
+/? mice. The ratio of T3/T4 was also evaluated as an
 
indication of the T4 converted to T3 through the action,of
 
T4 5'-monodeiodinase. No difference was observed in the
 
T3/T4 ratio for any of the treatment groups.
 
Daily Food Consumption
 
Daily food consumption was measured to confirm
 
leptin's role as a satiety factor and these data are shown
 
in figure 1. Vehicle treated ob/ob mice have a higher food
 
consumption than +/? vehicle treated mice. Leptin
 
treatment resulted in a depressed food consumption in ob/ob
 
mice relative to vehicle treated ob/ob mice. Food
 
consumption by iopanoic acid treated ob/ob mice remained
 
unchanged with respect to vehicle treated ob/ob mice,
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however it was greater than leptin treated ob/ob mice.
 
lopanpiG! acid + leptin treated ob/ob mice displayed a
 
similar food consumption to that df leptin treat ob/ob
 
mice, and it was significantly lower than both vehicle and
 
iopanoic acid treated ob/ob mice.
 
Body Weight Analysis
 
Bay 10 body weights for normal (+/?) and obese {fCb/ob)
 
mice are shown in Figure 2. All normal (+/?) treatment
 
groxips display equivalent body weights while vehicle ■ 
treated ob/ob mice had higher body weights than vehicle
 
treated +/? miee• Leptin treatment in ph/oh mice resulted
 
in lower body weights with respsot to vehicle treated ob/ob
 
mice. Obese mice treated with ioparioiC acid had body
 
weights equal to vehicle treated ob/ob mice.
 
Administration of iopainoic acid with leptin to ob/ob mice
 
caused the lowest body weights with respect to all ob/ob 
^ treatment groups. ■ 
Percent change in body weight relative to day 1 is 
used to show the relative changes in body weights for each 
treatment group (figure 3 a and b). Statistical analysis
 
was performed on day 10 percent changes by using arcsin
 
transformation. Percent change in body weights for
 
vehicle, leptin, iopanoic acid, and iopanoic acid + leptin
 
treated normal (+/?) mice displayed a similar slight
 
decrease, while iopanoic acid + leptin decreased more than
 
all other treatment groups by day 10 (figure 3a). Relative
 
to vehicle treated ob/ob mice, all ob/ob treatment groups
 
displayed a lower absolute body weight. Iopanoic acid
 
treated ob/ob mice show a smaller percent change in body
 
weight relative to ob/ob vehicle, while leptin and iopanoic
 
acid + leptin display lower body weights . Vehicle and
 
iopanoic acid treated ob/ob mice gained weight over the
 
/
 
course of the study, while leptin and iopanoic acid +
 
leptin treated ob/ob mice lost weight.
 
Thermogenic Response
 
Figure 4 shows that, on day 10, vehicle treated normal
 
+/? mice have a higher radiant body heat than vehicle
 
treated obese ob/ob mice. Leptin treated ob/ob mice have a
 
higher mean radiant body heat than vehicle treated ob/ob
 
mice, however the difference was not significant. Iopanoic
 
acid treatment did not result in a change in radiant body
 
heat in ob/ob mice relative to vehicle treated ob/ob mice,
 
however the administration of iopanoic acid with leptin
 
resulted in a higher thermogenic response relative to
 
vehicle treated ob/ob mice.
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Oxygen Consumption Analysis
 
Oxygen consumption rate (ml O2 " min was measured as
 
an indicator of metabolic expenditure. All day 10 normal
 
(+/?) treatment groups displayed no difference in total
 
oxygen consumption rat^ (figure 5). Leptin treatment in
 
ob/ob mice did not change oxygen consumption rate relative
 
to vehicle treated Ojb/oJb mice while iopanoic acid treated
 
ob/oJb mice had lower oxygen consumption rates relative to
 
both vehicle and leptin treated ob/ob mice, Leptin
 
treatment coupled with iopanoic acid prevented the decrease
 
in oxygen consumption rate relative to iopanoic acid
 
treatment alone. .
 
Respiratory Quotient
 
Respiratory quotients (RQ) were used to assess which
 
substrate (fat, carbohydrate, or protein) was primarily
 
metabolized by mice in each treatment group (figure 6).
 
Day 10 vehicle treated normal mice had RQ values below that
 
which would be calculated for pure fat metabolism. All
 
other normal and obese day 10 treatment groups had RQ
 
values that suggested fat metabolism.
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CHAPTER FOUR; DISCUSSION
 
Previous research has shown that food restricted obese
 
ob/ob mice display depressed levels of T3 and T4 relative to
 
normal mice (Oh and Kaplan, 1994). Results of the current
 
study contrast with Oh and Kaplan (1994) in that obese
 
(ob/ob) mice display significantly higher levels of serum T3
 
than vehicle treated normal (+/?) mice, whereas T4 levels in
 
+/? and ob/ob mice are equal. However, food restriction
 
has been shown to reduce plasma T3 levels (Cokelaere et al.,
 
1996; Oberkotter and Rasmussen, 1992), and since the mice
 
used in this study had free access to food, the differences
 
in serum thyroid levels observed between studies may
 
reflect the effects of food restriction.
 
Leptin has been shown to induce metabolic expenditure
 
(Pelleymounter et al., 1995) and previous research in the
 
host laboratory suggests that its action on peripheral
 
tissues may potentially be regulated through the induction
 
of thyroid hormone (Fehn et al., 1999). The obese ob/ob
 
mouse lacks functional leptin and was initially suspected
 
to display reduced serum T3 levels with respect to normal
 
mice, thus making it an excellent model to study the
 
effects of leptin replacement on T3 production. lopanoic
 
acid was used to inhibit T4 5'- monodeiodinase and thus
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prevent leptin's proposed ability to increase the
 
production of T3. All normal (+/?) mice displayed equal
 
quantities of serum T3 regardless of treatment, in spite of
 
the fact that +/IOP treated mice were predicted to display
 
significantly depressed T3 concentrations. Interestingly,
 
iopanoic acid was effective at reducing serum T3 levels in
 
ob/ob mice relative to vehicle treated ob/ob mice. The
 
form of iopanoic acid used in this study was different than
 
previously used in our laboratory and thus the pH stability
 
and effective dosages may have been different. Ideally a
 
preliminary iopanoic ^ cid dose response analysis should
 
have been performed.
 
In the current study leptin treated ob/ob mice
 
displayed a lower serum T3 concentrations as compared to
 
vehicle treated ob/ob controls (table 2). These results
 
and those reported by Fehn et al. (1999) Suggest that while
 
the thyroid gland activity is increased in leptin treated
 
ob/ob mice, the conversion of T4 to T3 remains low. It
 
should be noted that Fehn et al. (1999) reported increased
 
thyroid gland activity in leptin treated ob/ob mice and did
 
not measure serum thyroid hormone levels. The unexpected
 
hyperthyroid state observed in vehicle treated ob/ob mice
 
may be a mechanism to maintain a normal metabblism to
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cbmpensate for lack of leptiti. The data show that ibpanoic
 
acid was effective at lowering serum T3 in ob/ob mice
 
relative to vehicle treated oh/ob mice.
 
lopanoic acid was administered to inhibit the
 
conversion of T4 to T3, through blocking the functipb of ^ 4
 
5'- monodeiodinase and a reduction in the T3/T4 ratio with
 
respect to vehicle was expected. Ratios of T3/T4 display no
 
statistical difference among either +/? or ob/ob treatment
 
groups. However, the negative feedback action of T4 on
 
pituitary thyrotropin production might have lowered T4 and
 
produced a normalization of the T3/T4 ratio that would have
 
otherwise decreased due to the decline in T3 (Hadley, 1982).
 
Normal (+/?) vehicle treated mice represent those
 
whose appetite and metabolic expenditure are uninfluenced
 
by exogenous hormonal manipulation. Halaas et al. (1995)
 
reported that leptin treatment (12.5 /xg/g body weight) of
 
normal mice resulted in decreased food intake. They
 
attributed the reduced food intake to a decreased metabolic
 
demand resulting from a leptin induced reduction of body
 
weight. In the current study, leptin treatement (3 /xg/g
 
body weight) of +/? mice did not caUse a reduction of body
 
weight relative to vehicle treated +/? mice and thus their
 
exists no alteration in metabolic demand, as suggested by
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Halaas et al. (1995), and therfore a change in food
 
consTimption did not occur relative to vehicle treated
 
controls. Daily food consumption for iopanoic acid and
 
iopanoic acid + leptin treated +/? mice were also unchanged
 
compared to vehicle treated controls,
 
Leptin's role as a satiety factor is shown in vehicle
 
treated ob/ob mice whose inability to produce functional
 
leptin results in greater food consumption with respect to
 
normal mice (figure 1). The administration of leptin
 
inhibits feeding as seen by the observed depression of
 
daily food consumption relative to vehicle treated ob/ob
 
mice. Iopanoic acid treated ob/ob mice had lower levels of
 
serum T3 relative to vehicle treated ob/ob mice (table 2).
 
The inability of these mice to produce functional leptin as
 
well as an inability to increase synthesis of T3 most likely
 
accounts for the depressed metabolic rate (figure 5).
 
Since the metabolic rates decreased in iopanoic acid
 
treated ob/ob mice while food consumption remained
 
unchanged, it was expected that the iopanoic acid treated
 
ob/ob mice would display a body weight above that of
 
vehicle treated ob/ob mice. This did not occur and could
 
possibly be due to the chronic diarrhea observed in
 
iopanoic acid treated animals which continued for
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approximately 6-7 days from the beginning of treatment.
 
The comibined treatmeht of leptin and iopanoio acid
 
depressed food consumption below that observed in either
 
leptin or iopanbic acid treated V
 
Day 10 body weights; for normal i-k/?) mice were \
 
uhaffected by any treatment Cfigure 2). +/? treatment
 
groups consume similar ainouhts of food (figure 1), thus
 
supporting no observed change in body weights. The percent
 
change in body weight with respect to day 1 was calculated
 
from actual body weights and reported in figure 3 (a,b).
 
lopanoic acid + leptin treated +/? mice showed a lower
 
percent change in body weight relative to all other +/?
 
treatment groups. Obese (ob/ob) mice lack the ability to
 
synthesize functional leptin and this accounts for the
 
inability to effectively suppress appetite, which
 
contributes to the increase in body weight obseirved over
 
the course of the study. Both leptin and T3 have been
 
described as inducers of metabolic expenditure (Lombardi et
 
al., 1997; Mistry et al., 1997), but since ob/ob mice lack
 
leptin, the high T3 levels observed in vehicle treated ob/ob
 
mice relative to vehicle treated +/? mice is possibly a
 
physiological compensation for lack of leptin and thus
 
accounts for the similar total oxygen consumption in this
 
group relative to Vehicle treated +/? mice (figure 5).
 
Leptin treatment in ob/ob mice causes a significant
 
reduction in body weight compared to vehicle treated ob/ob
 
mice. This leptin effect is most likely the result of
 
appetite suppression/ which is consistent with the obseirved
 
reduction in food consiimption (figure 1), and increased
 
lipolytic activity (Shimabukuro et al 1997). The inability
 
of leptin to elevate radiant body heat and oxygen
 
consumption in leptin treated ob/ob mice lends support to
 
the idea that the body weight reduction was not the result
 
of induced metabolic expenditure. lopanoic acid treated
 
ob/ob mice lack leptin and display reduced serum T3 relative
 
to vehicle treated ob/ob mice (table 2). lopanoic acid
 
treated ob/ob show a high body weight relative to leptin
 
and iopanoic acid + leptin ob/ob mice due to the combined
 
absence of leptin as a Satiety factor and the reduced
 
metabolic rate associated with no leptin and the inability
 
to compensate through increasing thyroid hormone (T3).
 
Forty hours of fasting has been shown to reduce serum T4 and
 
T3 in rats by 28% and 38%, respectively (Kmiec et al.,
 
1998). Interestingly, after a 48 hour fast, both leptin
 
binding to the arcuate nucleus (ARC) and the density of
 
leptin receptors on the ARC has also been shown to increase
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by two-fold (Baskin et al., 1999). In the current study
 
iopanoic acid reduced serxim T3 by 50% relative to vehicle
 
treated mice. One might speculate that the expression of
 
leptin receptors on the arcuate nucleus are upregulated by
 
low levels of T3, and thus increases leptin sensitivity.
 
This wpuid support both a gresater inhibition of feeding
 
leading to a larger decrease in body weight in the iopanoic
 
acid + leptin treated ob/ob mice relative to ob/ob mice
 
treated with iopanoic acid alone.
 
Oxygen consumption and carbon dioxide production were
 
used to calculate the respiratory quotient (RQ) to provide
 
an indication of the metabolic substrate. An RQ value of
 
0.71 indicates that fats are being used as the primary
 
source of fuel. Normal +/? vehicle treatment group
 
displayed a day 10 RQ value below 0.71 (0.62 +005). An
 
RQ value below 0.71 is indicative of either metabolic
 
alkalosis associated with hyperventilation, or a large
 
oxygen uptake after exercise so as to replenish an oxygen
 
debt (Schmidt-Nielson, 1990). It is unclear as to whether
 
an RQ value below 0.71 in vehicle treated +/? mice was due
 
to experimental error or the above mentioned variables.
 
All other +/? treatment groups had day 10 respiratory
 
quotients that suggested fats as a primary source of fuel
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(figure 6). All day 10 obese (ob/ob) mice display RQ
 
values that also indicate the utilization of fats. All RQ
 
data seems unreliable.
 
Intracerebroventricular and systemic injections of
 
leptin have both been shown to increase metabolic rate
 
(Pelleymounter et al., 1995; Mistry et al., 1997; Ghibaudi
 
et al., 1996). Although the pathway by which leptin causes
 
metabolic induction has not been fully identified, research
 
has provided evidence that both sympathetic activation via
 
the central nervous system (Haynes et al., 1997) and T3
 
induction (Fehn et al., 1999) remain the two major
 
possibilities. A reduction in serum T3 accompanied a
 
depressed oxygen consumption in iopanoic acid treated ob/ob
 
mice relative to vehicle treated ob/ob mice, suggesting
 
that T3 was a major determinant of metabolic rate in fed
 
ob/ob mice (figure 5). Interestingly, by maintaining a
 
depressed T3 state, relative to vehicle ob/ob mice, and
 
reintroducing leptin in iopanoic acid + leptin treated
 
ob/ob mice, we observed a similar oxygen consumption
 
relative to vehicle treated ob/ob mice (figure 5). This
 
suggests that the leptin induced metabolic recovery does
 
not require an upregulation of T3. Thus, sympathetic
 
activation apparently plays a much greater role in leptin
 
38
 
influenced metabolism than does T3. Furthermore, while T3
 
levels remain depressed in both leptin and iopanoic acid +
 
leptin treated ob/ob mice relative to vehicle treated ob/ob
 
mice, mean radiant body heat is higher in both groups
 
relative to the same control group (it should be noted that
 
leptin elevated radiant body heat relative to vehicle
 
treated ob/ob mice was not significant).
 
Studies support the thermogenic role of leptin acting
 
through increased thermogenic activity and an upregulation
 
of uncoupling protein 3 (Gong et al., 1997; Ghibaudi et
 
al., 1996). Furthermore, it has been clearly established
 
that leptin functions to increase metabolic rate through
 
the upregulation of uncoupling proteins and oxygen
 
consumption in the ob/ob mouse (Cinti et al., 1997; Mistry
 
et al., 1997). However, it has not been shown whether
 
leptin is able to act on peripheral tissue upregulation of
 
thermogenic activity or corresponding metabolic rate in the
 
absence of T3 induction. Leptin induced heat production and
 
oxygen consumption in iopanoic acid + leptin ob/ob mice
 
relative to iopanoic acid ob/ob mice may be partially
 
attributed to an upregulated proton leak via skeletal
 
muscle uncoupling.
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The heat produced by the body is used to maintain a
 
relatively constant body temperature. Thus any excess heat
 
that is produced as a result of either extrinsic factors,
 
such as leptin or thyroid hormone administration, or
 
intrinsic stimulation is emitted from the body surface.
 
Infrared emission was used as ah indicator of radiant body
 
heat with the arg\iment that heat emitted from siobcutaneous
 
vascularization is uninhibited by alterations in fat
 
insulation. Therefore, radiant body heat was used as an
 
accurate indicator of heat production in excess to that
 
which is used in maintaining a core body temperature. A
 
lower radiant body heat for vehicle treated ob/ob mice,
 
relative to +/? mice is interpreted as a reduced ability to
 
produce excessive heat to that which is used to maintain
 
constant body temperature and thus results in a lower
 
infrared emission. Interestingly, the high T3 levels
 
associated with vehicle treated ob/ob mice indicates that
 
the low radiant body heat observed in this group, relative
 
to vehicle treated +/? mice, is not due to the T3 state.
 
Leptin's role as an inducer of metabolic expenditure
 
suggests that an increased radiant body heat should be
 
observed for leptin treated ob/ob mice relative to vehicle
 
treated ob/ob mice. However, radiant body heat in leptin
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treated db/pb mice was not elevated with respect tp vehicle
 
treated ob/ob mice. In comparison, Pelleymounter et al.
 
(1995) observed an significant increase in core body-

temperature, however they administered leptin to ob/ob mice
 
at over 3 times concentration used in this study and for
 
over 3 times as long. The lack of a detectable thermogenic
 
response in the current study is likely due to the lower
 
dose of leptin used and because the infrared emission
 
method measures excess radiant heat rather than core body
 
temperature.
 
Leptin treatment alone (3 |.ig/g) did not change oxygen
 
consumption in ob/ob mice relative to vehicle treated ob/ob
 
mice. However, Pelleymounter et al.(1995) observed a
 
leptin induced oxygen consumption in ob/ob mice at
 
10 |ig/g but not at 0.1 fj,g/g or 1.0 |a.g/g. Interestingly,
 
while iopanoic acid treatment reduced oxygen consumption in
 
ob/ob mice relative to vehicle treated ob/ob mice,
 
simultaneous administration of leptin preserved oxygen
 
consumption rates equivilant to vehicle treated ob/ob
 
levels. While oxygen consumption in iopanoic acid + leptin
 
ob/ob mice was restored to control (vehicle ob/ob mice)
 
levels, serum thyroid (T?) levels were not restored to
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 control levels (vehicle ob/ob mice). Furthermore, leptin
 
and ippanoic acid + leptin ob/ob mice display elevated
 
radiant body heat relative to both iopanoic acid and
 
vehicle treated ob/ob mice. These data suggest that leptin
 
is able to induce thermogenesis and oxygen consumption
 
without upregulating the synthesis of T3.
 
Both leptin induced thermogenesis and oxygen
 
consumption rates provide evidence suggestive of metabolic
 
uncoupling, but they do not conclusively demonstrate this
 
phenomena. Stronger evidence of uncoupling protein
 
incorporation into the mitochondrial membrane would include
 
the maintenance of metabolic rate accompanied by a rise in
 
thermogenesis. However since leptin induces enzymes
 
associated with increased metabolism, such as acyl CoA
 
oxidase and carnitine palmitoyl transferase, an increas in
 
metabolism will always accompany a rise in thermogenesis
 
(Wang et al,, 1999; Zhou et al., 1997; Zhou et al., 1999).
 
There exists much evidence of leptin's ability to induce
 
metabolic uncoupling. However, with advances in our
 
understanding of leptin's signalling pathways, it is
 
becoming apparent that there exists alternative pathways
 
through which leptin is able to stimulate peripheral tissue
 
metabolic uncoupling. For instance, Mistry et al. (1997)
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and Wang et al. (1999) provide support of leptin's ability
 
to stimulate thermogenesis via induction of adrenal
 
synthesis of catecholamines. A rise in catecholamine
 
levels induces lipolytic enzymes and increases fatty acid
 
levels, which in turn induce vmcoupling protein synthesis
 
(Weigle et al., 1998). The current study was designed to
 
evaluate a proposed mechanism by which leptin acts on
 
peripheral tissue metabolic expenditure and thermogenesis
 
through the upregulation of thyroid hormone (T3). The
 
results of the study show that while T3 levels are
 
suppressed in iopanoic acid treated ob/ob mice, leptin is
 
still able to induce both metabolic expenditure and
 
thermogenesis. Further studies should be done to elucidate
 
whether the observed increase in radiant body heat is the
 
result of tissue specific upregulation of uncoupling
 
protein.
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Table 2. Serum thyroid hormone concentrations (T3 and T4)
 
and the ratio of T3/T4 for day 10 normal (+/?) and obese
 
{ob/ob) mice. Vehicle treated obese mice displayed
 
significantly elevated T3 concentrations with respect to all
 
normal and obese treatment groups. Normal leptin treatment
 
group displayed a reduced serum T4 concentration with
 
respect to iopanoic acid + leptin treated obese mice. No
 
significant differences were observed in the T3/T4 for any
 
treatment groups. An outlier occurred for a single animal
 
in the T3/T4 for vehicle treatment (after the division
 
calculation), thus it was removed and a missing data point
 
was generated (n=4 was used to calculate ANOVA). Missing
 
data points occurred in vehicle normal T3 (n=4 was used to
 
calculate ANOVA), and iopanoic acid obese T3 (n=4 was used
 
to calculate ANOVA).
 
T3(ng/dl) T4(Mg/dl) T3/T4(ng/pg)
 
Normal(+/?) Vehicle 96.9+ 21.0 4.0+0.8 23.1+6.5
 
Leptin 64.1 +33.6 2.4+0.5 28.3+ 15.4
 
Iopanoic Acid 91.8+40.3 3.8 +0.8 24.9+9.7
 
Iopanoic Acid + Leptin 102.6+ 9.6 3.2+0.4 32.6+6.52
 
Obese(ob/ob) Vehicle 197.1 +44.3 3.5+ 1.7 41.6+6.7
 
Leptin 116.8+ 23.3 3.3+0.5 35.3+6.7
 
Iopanoic Acid 100.7+ 21.2 4.1 + 1.3 26.2+4.9
 
Iopanoic Acid + Leptin 120.7+ 38.0 4.4+ 1.2 30.3+ 17.6 ­
+/V +/L +/I0P +/IOP-L ob/L ob/lOP ob/IOP-L
T3
 
ob/V s S s S s s s
 
+/V +/L +/I0P +/I0P-L Ob/L ob/lOP ob/IOP-L
T4
 
ob/lOP-L NS S NS NS NS NS
 
Symbols are defined as follows: +/V = vehicle treated +/?;
 
+/L = Leptin treated +/?; +/IOP = Iopanoic acid treated
 
+/?; +/IOP-L = Iopanoic acid plus leptin treated +/?.
 
Obese (ob/ob) mice received same treatments but are
 
represented with the symbol ob/ . Statistical
 
significance is shown in chart below table where treatment
 
groups intersect (S = significance; NS = not significant).
 
T3 and T4 statistical significant charts are separate, while
 
no T3/T4 chart is shown due to there being no significant
 
difference between treatment groups. All values are mean +
 
SD.
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Figure 1. Mean daily food consumption for each treatment
 
group of normal {+/?) and obese (oJb/oJb) mice (grams/day
 
total for each cage). Mean food consumption was analyzed
 
on the last 3 days (days 8-10). Obese (oh/oh) mice display
 
increased food consumption as compared to vehicle treated
 
normal (+/?) mice. Leptin treatment in ob/ob mice caused a
 
decrease in food consumption relative to +/? vehicle
 
treated mice. lopanoic acid + leptin treated ob/ob mice
 
displayed a decreased food consumption relative to both
 
vehicle treated +/? and iopanoic acid treated ob/ob mice.
 
Symbols are defined as follows: +/V= vehicle treated +/?;
 
+/L= Leptin treated +/?; +/I0P= lopanoic acid treated +/?;
 
+/I0P-L= lopanoic acid plus leptin treated +/?. Obese
 
(ob/ob) mice received the same treatments but are
 
represented with the symbol ob/ . Statistical
 
significance is shown in a chart below the figure where
 
treatment groups intersect (S = significance; NS = not
 
significant). Values are mean + SD, n=3.
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Figure 2. Day 10 body weight for each treatment group of
 
normal {+/?) and obese {ob/pb) mice. All normal +/?
 
treatment groups remained the same body weight. Vehicle
 
treated obese mice display body weight higher than vehicle
 
treated normal mice* Leptin treatment in obese mice caused
 
a reduction in body weights with respect to vehicle treated
 
obese mice. lopanoic acid treated obese mice had higher
 
body weights than both leptin and iopanoic acid + leptin
 
treated obese treatment groups. lopanoic acid + leptin
 
treated obese mice displayed lower body weights than both
 
leptin and iopanoic acid treatment groups. Symbols are
 
defined as follows: +/V= vehicle treated +/?; +/L= Leptin
 
treated +/?; +/I0P= iopanoic acid treated +/?; +/lOP-L==
 
lopanoic acid plus leptin treated +/?. Obese (ob/ob) mice
 
received the same treatments but are represented with the
 
symbol Ob/ . Statistical significance is shown in a chart
 
below the figure where treatment groups intersect
 
(S = significance; NS = not significant). Values are mean
 
+ SD, n=5.
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Figure 3 (a,b) . Percent change in body weight with 
to day 1 for normal (a) and obese (b) mice. Mice were 
treated with either vehicle (V) , leptin (L) , iopanoic acid 
(lOP) , or iopanoic acid + leptin (lOP-L, lines which 
correspond to each treatment are displayed in the figures) . 
ANOVA was used to analyze percent change with respect to 
day 1 of body weights for the final day. In order to 
statistically evaluate all values of percent change as 
positive numbers, a constant of 0.25 was added to the 
percent change of each animal and then arcsin 
transformation was applied to each the values (Zar,1984) . 
Values are mean + standard deviation, n=5. 
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Figure 4. Day 10 radiant body heat (°C) for each treatment
 
group of normal (+/?) and obese (ob/ob) mice. Normal
 
animals were unchanged by any treatment. Vehicle treated
 
obese mice display a lower radiant body heat than vehicle
 
treated normal mice. lopanoic acid treated obese mice show
 
a radiant body heat lower than both leptin and iopanoic
 
acid + leptin treated obese mice. lopanoic acid + leptin
 
treated obese mice have a higher radiant body heat than
 
both vehicle and iopanoic acid treated obese mice. Symbols
 
are defined as follows: +/V= vehicle treated +/?; +/L=
 
Leptin treated +/?; +/IOP= lopanoic acid treated +/?;
 
+/lOP-L= lopanoic acid plus leptin treated +/?. Obese
 
(ob/ob) mice received the same treatments but are
 
represented with the symbol ob/ . Statistical
 
significance is shown in a chart below the figure where
 
treatment groups intersect
 
(S = significance; NS = not significant). Values are mean
 
+ SD, n=5.
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Figure 5. Day 10 oxygen consumption rate (ml O2 . min ")
 
for day 10 normal (+/?) and obese {ob/ob) mice. lopanoic
 
acid treated obese mice display a reduced oxygen
 
consumption rates relative to the noted treatment groups in
 
the chart. Symbols are defined as follows: +/V (day)="
 
vehicle treated +/?; +/L = Leptin treated +/?; +/IOP =
 
lopanoic acid treated +/?; +/IOP-L = lopanoic acid plus
 
leptin treated +/?. Obese {ob/ob) mice received the same
 
treatments but are represented with the symbol ob/ .
 
Statistical significance is shown in a chart below the
 
figure where treatment groups intersect (S = significance;
 
NS = not significant). Values are mean + SD, n=5.
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Figure 6. Respiratory quotients (RQ) for day 10 normal
 
(+/?) and obese {ob/ob) treatment groups. Day 10 vehicle
 
and leptin treated obese mice display an RQ value above
 
vehicle treated normal mice. Symbols are defined as
 
follows: +/V (day)= vehicle treated +/?; +/L = Leptin
 
treated +/?; +/IOP = lopanoic acid treated +/?; +/IOP-L =
 
lopanoic acid plus leptin treated +/?. Obese {ob/ob) mice
 
received the same treatments but are represented with the
 
symbol ob/ . Statistical significance is shown in a
 
chart below the table where treatment groups intersect (S =
 
significance; NS = not significant). Values are mean + SD,
 
n=5.
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Appendix C. Radiant body heat (°C) for day 1 and day 10
 
normal (+/?) and obese (ob/ob) mice. Radiant body heat is
 
not different between any groups on day 1. There are no
 
significant temperature changes between day 1 and day 10
 
for any normal treated group- All obese treated groups
 
display decreased radiant body heat from day 1 to day 10.
 
Day 10 iopanoic acid + leptin treated obese mice are
 
significantly higher than day 10 vehicle and day 10
 
iopanoic acid treated obese mice. Symbols are defined as
 
follows: +/V (day)= vehicle treated +/?; +/L (day)= Leptin
 
treated +/?; +/IOP (day)= Iopanoic acid treated +/?; +/IOP­
L (day)= Iopanoic acid plus leptin treated +/?. Obese
 
{ob/ob) mice received the same treatments but are
 
represented with the symbol ob/___ (day). Statistical
 
significance is shown in a chart below figure where
 
treatment groups intersect (S = significance; NS = not
 
significant). Statistical analysis was performed using
 
Repeated Measure Analysis of Variance. Values are mean +
 
SP, n=5.
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)pendix D'. Oxygen consumption rates (ml O2 . min'^)
 
days 1 and 10 for normal {+/?) and obese mice. All normal
 
and obese mice had eqiiivalant day 1 oxygen cohsiomption rate
 
values. lopanoic acid treated obese mice display a reduced
 
day 10 oxygen consumption relative to day 1 and all other
 
day 10 obese treatment groups. Symbols are defined as
 
follows: +/V (day)= vehicle treated +/?; +/L (day)= Leptin
 
treated +/?; +/IOP (day)= lopanoic acid treated +/?; +/IOP­
L (day)= lopanoic acid plus leptin treated +/?. Obese
 
(ob/oh) mice received the same treatments but are
 
represented with the symbol ob/ (day). Statistical
 
significance is shown in a chart below the table where
 
treatment groups intersect (S = significance; NS = not
 
significant). Statistical analysis was performed using
 
Repeated Measure Analysis of Variance. Values are mean _+
 
SD, n=5.
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Appendix E. Respiratory quotient (RQ) for day 1 and day 10
 
comparison of normal (+/?) and obese (ob/ob) treatment
 
groups. All day 1 treatment groups, except for the
 
iopanoic acid + leptin obes mice, have RQ values that
 
suggest fat metabolism. All day 10 treatment groups have
 
RQ values that indicate fat metabolism. Symbols are
 
defined as follows: +/V (day)= vehicle treated +/?; +/L
 
(day)= Leptin treated +/?; +/IOP (day)= Iopanoic acid
 
treated +/?; +/IOP-L (day)= Iopanoic acid plus leptin
 
treated +/?. Obese (ob/ob) mice received same treatments
 
but are represented with the symbol ob/_ (day).
 
Statistical significance is shown in^ chart below table
 
where treatment groups intersect (S = significance; NS =
 
not significant). Statistical analysis was performed using
 
Repeated Measure Analysis of Variance. Values are mean +
 
SD, n=5.
 
53
 
REFERENCES
 
Auwerx, J., and B. Staels. "Leptin." Lancet 35:737-742,
 
1998.
 
Bai, Y., S. Zhang, K. S. Kim, J. K. Lee, and K. H. Kim.
 
"Obese gene expression alters the ability of 30A5
 
preadipocytes to respond to lipogenic hormones." J.
 
Biol. Chem. 271:13939-13942, 1996.
 
Baskin, D. G., J. F. Breininger, S. Bonigut, and M. A.
 
Miller. "Leptin binding in the arcuate nucleus is
 
increased during fasting." Brain Research 828:154-158,
 
1999.
 
Baskin, D. G., J. F. Breininger, and M. W. Schwartz. Leptin
 
receptor mRNA identifies a subpopulation of
 
neuropeptide Y neurons activated by fasting in rat
 
hpothalamus." Diabetes 48:828-833, 1999.
 
Boss, O., S. Samec, A. P. Giacobino, C. Rossier, A. Dulloo,
 
J. Seydoux, P. Muzzin, and J. P. Giacobino.
 
"Uncoupling protein-3: a new member of the
 
mitochondrial carrier family with tissue-specific
 
expression." FEBS Letters. 408:39-42, 1997.
 
Brand, M. D., L. F. Chien, E. K. Ainscow, D. F. S. Rolfe,
 
and R. K. Porter. "The causes and functions of
 
mitochondrial proton leak." Biochim. Biophys. Acta.
 
1187:132-139, 1994.
 
Brown, G. C., P. L. Lakin-Thomas, and M. D. Brand. "Control
 
of respiration and oxidative phosphorylation in
 
isolated rat liver cells." Eur. J. Biochem. 192:355­
362, 1990.
 
Cannon, B., A. Hedin, and J. Nedergaard. "Exclusive
 
occurrence of thermogenin antigen in brown adipose
 
tissue." FEBS Letters 150:129-132, 1982.
 
Cannon, B., D. Nicholls, and G. L. Lindberg. "Purine
 
nucleotides and fatty acids in energy coupling of
 
mitochondria from brown adipose tissue." Mechanisms in
 
Bioenergetics. Edited by G. F. Azzone, L. Ernster, S.
 
Papa, E. Quagliariello, and N. Siliprand. New York:
 
Academic Press. 1973, pp. 357-363.
 
54
 
Cinti, S., R. C. Frederich, M. C. Zingaretti, R. D.
 
Matteis, J/ S/ Flier, and B. B. Lowell.
 
"Immunohistochemical localization of leptin and
 
uncoupling protein in white and brown adipose tissue
 
Endocrinology 138:797-804, 1997.
 
Cokelaere, M., E. Decuypere, G. Flo, V. M. Darras, and E.
 
R. Kuhn. "Influence of feeding pattern on thyroid
 
hormones in long-term food-restricted rats." Horm.
 
Metab. Res. 28:315-318, 1996.
 
Cunningham, S., P. Leslie, D. Hopwood, P. Illingworth, R.
 
T. Jung, D. G. Nicholls, N. Peden, J. Rafael, and E.
 
Rial. "The characterization and energetic potential
 
of brown adipose tissue in man." Clinical Science
 
69:343-348, 1985.
 
Fehn, R., C. Clark. "Leptin and thyroid hormone in lipid
 
trafficking: a comparison in ob and db mice." FASEB
 
Journal 14:A736, 2000.
 
Fehn, R., C. Clark, P. Galicia, and B. Underbill. "Leptin
 
restores metabolism by correcting the hypothyroid
 
status of ob/ob mice." FASEB Journal 13:A343, 1999.
 
Fleury, C., M. Neverova, S. Collins, S. Raimbault, O.
 
Champigny, C. Levi-Meyrueis, F. Bouillaud, M. F.
 
Seldin, R. S. Surwit, D. Ricquier, and C. H. Warden.
 
"Uncoupling protein-2: A novel gene linked to obesity
 
and hyperinsulinemia." Nature Genet. 15:269-272, 1997.
 
Flier, J. S., and B. B. Lowell. "Obesity research springs a
 
proton leak." Genetics 15:223-224, 1997.
 
Garlid, K. D., D. E. Orosz, M. Modriansky, S. Vassanelli,
 
and P. Jesek. "On the mechanism of fatty acid-induced
 
proton transport by mitochondrial uncoupling protein."
 
J. Biol. Chem. 271:2615-2620, 1996.
 
Garruti, G., and D. Ricquier. "Analysis of uncoupling
 
protein and its mRNA in adipose tissue deposits of
 
adult hximans." Int. J. Dbes. Relat. Metab. Disord.
 
16:383-390, 1993.
 
Ghibaudi, A. J. J., D. Compton, A. B. Fawzi, C. D. Strader.
 
"Intracerebroventricular injection of leptin increases
 
thermogenesis and mobilizes fat metabolism in ob/ob
 
mice." Horm. Metab. Res. 28;659-663, 1996.
 
Gimeno, R. E.> M. Dembski, X. Weng, N. Deng, A. W. Shyjan,
 
G. J. Gimeno, F. Iris, S. J. Ellis, E. A. Woolf, and
 
L, A- Tartaglia. "Cloning and characterizationof an
 
uncoupling protein homolog: A potential molecular 
mediator of human thermogenesis," Diabetes 46:900-906, 
^991• ■ ■ ■ 
Gong, D. Wl, Y. He, M. Karas, and M. Reitman. "Uncoupling
 
protein-3 is a mediator of thermogenesis regulated by
 
thyroid hormone, beta 3-adrenergic agonists, and
 
leptin." J. Biol. Chem. 272:24129-24132, 1997.
 
Hadley, M E. "Endocrinology." Prentice-Hall, Inc., 1988
 
p.325
 
Hagstrom-Toft, S. Enoksson, E. Moberg, J. Bolinder, P.
 
Arner. "Beta-adrenergic regulation of lipolysis and
 
blood flow in human skeletal muscle in vivo." Am. J.
 
Physiol. 275:E909-E916, 1998.
 
Halaas, J. L., K. S. Gajiwala, M. Maffei, S. L. Cohen, B.
 
T. Chait, D. Rabinowitz, R. L. Lailone, S. K. Burley,
 
J. M. Friedman. "Weight-reducing effects of the plasma
 
protein encoded by the obese gene." Science 269:543­
546, 1995. :
 
Haynes, G. W., A. D. Morgan, A . S. Walsh, L. A. Mark, I.
 
and W. Sivitz. "Receptor-mediated regional sympathetic
 
nerve activation by leptin." J, Clin. Invest. 100:270­
278, 1997.
 
Heaton, G. M., R. J. Wagenvoord, A. Kemp, and D. G.
 
Nicholls. "Brown adipose tissue mitochondria:
 
photoaffinity labelling of the regulatory site energy
 
dissipation." Eur. J. Biochem. 82:515-521, 1978.
 
Heim, T., and D. Hull. "The blood flow and oxygen
 
consxamption of brown adipose tissue in the new-born
 
rabbit." J. Physiol. London 186:42-55, 1968.
 
Himms-Hagen, J. "Brown adipose tissue thermogenesis and
 
obesity." Prog. Lipid Res. 28:67-115, 1989.
 
56
 
Himms-Hagen, J. "Brown adipose tissue thermogenesis:
 
Interdisciplinary studies." FASEB Jo. 4;2890-2898,
 
/ 1990\ .
 
Hittelman, K. J., O. Mndb and B. Cannon. "Oxidative
 
phosphorylation and compartmentation of fatty acid
 
metabolism in brown fat mitochondria." Eur. J.
 
Biochem. 11;183-192, 1969.
 
Hua, L., M- Matheny, J. P. Scarpace. "Beta 3-adrenergic­
mediated suppression of leptin gene expression in
 
ratS." Am. J. Physiol. 273:E1031-E1036, 1997.
 
Hwang, C. S., and M. D. Lane. "Up-regulation of uncoupling
 
protein-3 by fatty acid in C2ei2 myotubes." Biochem.
 
Biophys. Res. Commun. 258:464-469, 1999,
 
Jezek, P., H. Engstova, M. Zackova> A. E.Vercesi, A. D. T.
 
CoSta, P. Arruda, and K. D. Garlid. "Fatty acid
 
cycling mechanism and mitochondrial uncoupling
 
proteins." Biochim. Biophys. Acta. 1365; 319­
321, 199:8.. ;,
 
Kaplan, M. L., and G. A. Leveille. "Core temperature, O2
 
consiimption and early detection of ob/ob genotype in
 
mice. Am. J. Physiol. 227;912-915, 1974.
 
Klaus, S., L. Casteilla, F. Bouillaud, D. Ricquier. "The
 
uncoupling protein UCP: A membraneous mitochondrial
 
ion carrier exclusively expressed in brpwn adipose
 
tissue♦" int. J. Biochem. 23:791-801, 1991. 
Klingenberg, M. "Dialectics in carrier research: The 
ADP/ATP carrier and the uncoupling protein." J. 
Bioenerq. Biomembr. 25;447-457, 1993. 
Klingenberg, M. and E. Winkler. "The reconstituted isolated 
uncoupling protein is a membrane potential driven H* 
translocator." The EMBO Journal 4;3087-3092, 
1985. 
Kmiec, Z., G. Kotlarz, B. Smiechowska, and A. Mysliwski. 
"The effect of fasting and refeeding on thyroid 
follicle structure and thyroid homone levels in young 
and old rats." Arc. of Gerentol. arid Geriatr. 
26:161-175, 1998. 
57 
Kotz, C. M., J. E. Briggs, J. D. Pomonis, M. K. Grace, A.
 
S. Levine, and C. J. Billington. "Neural site of
 
leptin influence on neuropeptide Y signalling pathways
 
altering feeding and uncoupling protein. Am. J.
 
Physiol. 275(2pt2);R478-R484, 1998.
 
Schmidt-Nelson, K. "Animal Physiology." Cambridge
 
University Press, 1990, p. 172, 254.
 
Lean, M. E., W. P. James, G. Jennings, and P. Trayhurn.
 
"Brown adipose tissue uncoupling protein content in
 
human infants, children and adults." Clin. Sci.
 
(Colch) 71:291-297, 1986.
 
Lin, C. S., and M. Klingenberg. "Characteristics of the
 
isolated purine nucleotide binding protein from brown
 
fat mitochondria." Biochemistry 21;2950-2960/ 1982.
 
Liu, Q., C. Bai, F. Chen, R. Wang, T. MacDonald, M. Gu, Q.
 
Zhang, M. A. Morsy, and C. T. Caskey. "Uncoupling
 
protein-3: A muscle-specific gene upregulated by
 
leptin in oh/ob mice." Gene 207:1-7, 1998.
 
Lombardi, A., M. Moreno, C. Horst, F. Goglia, and A. Lanni,
 
"Characterization of the binding of 3,3'-di-iodo-L-

Thyronine to rat liver mitochondria." J. Endocrin.
 
154:119-124, 1997.
 
Mao, W., X. X. Yu, A. Zhong, W. Li, J. Brush, S. W.
 
Sherwood, S. H. Adams, and G. Pan. "UCP4, a novel
 
brain-specific mitochondrial protein that reduces
 
membrane potential in mammalian cells." FEBS Letters.
 
443:326-330, 1999.
 
Mason, R., R. Gunst, and J. Hess. "Statistical Design and
 
analysis of experiments." New York, John Wiley & Sons,
 
1989, p. 301 and 347.
 
Millet, L., H. Vidal, D. Larrouy, F. Andreelli, M. Laville,
 
and D. Langin, "mRNA expression of the long and short
 
forms of uncoupling protein-3 in obese and lean
 
humans." Diabetologia. 41:829-832, 1998.
 
Mistry, A. M., A. G. Swick, and D. R. Romsos. "Leptin
 
rapidly lowers food intake and elevates metabolic
 
rates in lean and ob/ob mice." J. Nutr. 127:2065-2072,
 
1997.
 
Nagase, I., T. Yoshida, K. Kxamamoto, T. Umekawa, N. Sakane,
 
H. Nikami, T. Kawada, and M. Saito. "Expression of
 
uncoupling protein in skeletal muscle and white fat
 
of obese mice treated with thermogenic beta 3­
adrenergic agonist." J. Glin. Invest. 97:2898-2904,
 
1996.
 
Nicholls, D. G., and R. M. Locke. "Thermogenic mechanisms
 
in brown fat." Physiol. Rev. 64:1-64, 1984.
 
Nobes, C. D., G. C. Brown, P. N. Olive, and M. D. Brand.
 
"Non-ohmic proton conductance of the mitochondrial
 
inner membrane in hepatocytes." J. Biol. Chem.
 
265:12903-12909, 1990.
 
Oberkotter, L. V., K. M. Rasmussen. "Changes in plasma
 
thyroid hormone concentrations in chronically food-

restricted female rats and their offspring during
 
suckling." J. Nutr. 122:435-441, 1992.
 
Oh, S. S., M. L. Kaplan. "Early treatment of obese (ob/ob)
 
mice with triiodothyronine increases oxygen
 
consumption and temperature and decreases body fat
 
content." Proc. Soc. Exp. Biol. Med. 207:260-267,
 
1994.
 
Palmieri, F. "Mitochondrial carrier proteins." FEBS
 
Letters. 346:48-54, 1994.
 
Pelleymounter, M. A., M. J. Cullen, M.B. Baker, R. W. D.
 
Hecht, B. Thomas, arid F. Collins. "Effects of the
 
obese gene product on body weight regulation ob/ob
 
mice." Science 269:540-543, 1995.
 
Podolsky, R. J., and F. M. Morales. "The enthalpy change of
 
adenosine triphosphate hydrolysis." J. Biol. Chem.
 
218: 945-956, 1956.
 
Prolo, P., M. L. Wong, and J. Licinio. "Leptin." Int. J.
 
Bio, and Cell Bio. 3:1285-1290, 1998.
 
Prusiner, S., and M. Poe. "Thermodynamic considerations of
 
mammalian thermogenesis." Nature 220:235-237, 1968.
 
Rafael, J., H. J. Ludolph, and H. J. Hohorst. "Mitochondria
 
from brown adipose tissue: Uncoupling of oxidative
 
phosphorylation by long chain fatty acids and
 
59
 
recoupling by guanosine triphosphate." Hoppe-Seyler/s
 
Z. Physiol. Chem. 350:1121-1131, 1969.
 
Rolfe, D. F. S., G. G. Brown. "Cellular energy utilization
 
and molecular origin of standard metabolic rate in
 
mammals." Physiol. Rev. 77;731-758, 1997.
 
Rolfe, D. F. S., and M. D. Brand. "The contribution of
 
mitochondrial proton leak to the
 
rat of respiration ih rat skeletal muscle and to SMR."
 
Am. J. Physiol. 271:C1380-C1389, 1996.
 
Rolfe, D. F. S., A. J. Hulbert, and M. D. Brand.
 
"Characteristics of mitochondi^ial proton leak and
 
control of oxidative phosphorylation in the major
 
oxygen consuming tissues of the rat. Biochim. Biophys.
 
Acta. 1188:405-416, 1994.
 
Satoh, N., O. Yoshihiro, G. Katsuura, Y. Numdta, T. Tsuji,
 
M. Hayase, K. Ebihara, H. Masazaki, K. Hosoda, Y.
 
Yoshimasa, and K. Nakao. "Sympathetic activation of
 
leptin via the ventromedial hypothalamus." Diabetes
 
48:1787-1793, 1999.
 
Schmidt-Neilsen, Knut. "Animal Physiology: Adaption and
 
Environment." Press Syndicate of the University of
 
Cambridge, 1990, p. 172.
 
Shimabukuro, M., K. Koyama, G. Chen, M. Y. Wang, F. Trieu,
 
Y. Lee, C. B. Newgard, and R. H. Unger. "Direct
 
antidiabetic effect of leptin through triglyceride
 
depletion of tissues." Proc. Nat. Acad. Sci. USA.
 
94:4637-4641, 1997.
 
Solanes, G., A. Vidal-Puig, D. Grujic, J. S. Flier, and B.
 
B. Lowell. "The human uncoupling protein-3 gene.
 
Genomic structure, chromosomal localization, and
 
genetic basis for short and long form transcripts." J.
 
Biol. Chem. 272:25433-25436, 1997.
 
Vidal-Puig, A., G. Solanes, D. Grujic, J. S. Flier, and B.
 
B. Lowell. "UCP3: An uncoupling protein homologue
 
expressed preferentially and abundantly in Skeletal
 
muscle and brown adipose tissue." Biochem. Biophys.
 
Res. Commun. 235:79-82, 1997.
 
60
 
 Wang, M.-Y., Y. Lee, and R. H. Unger. "Novel form of
 
lipolysis induced by leptin." J. of Bio. Chem.
 
274;17541-17544, 1999.
 
Weigle, D. S,, L. E. Selfridge, M. W. Schwartz, R. J.
 
Weely, D. E. Cummings, P. J. Havel, J. L. Kuijper, and
 
H. Beltrandelrio. "Elevated free fatty acids induce
 
uncoupling protein 3 expression in muscle." Diabetes
 
47:298-302, 1998.
 
Zar, J. H. "Biostatistical Analysis." Prentice-Hall, Inc.
 
1984. p. 216, 238.
 
Zhou, Y. T., M. Shimabukuro, K. Koyama, Y. Lee, M. Y.
 
F. Trieu, C. B. Newgard, and R. H. Unger. "Induction
 
by leptin of uncoupling protein-2 and enzymes of fatty
 
acid oxidation." Proc. Nat. Acad. Sci. USA. 94:6386­
6390, 1997.
 
Zhou, Y. T., M. Shimabukuro, K. Koyama, Y. Lee, M. Y. Wang,
 
F. Trieu, C. B. Newgard, and R. H. Unger. "Reversing
 
adipocyte differentiation: Implications for treatment
 
of obesity." Proc Natl. Acad. Sci. USA. 96:2391-2395,
 
■ , 1999. 
61
 
